CULLINAN THERAPEUTICS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | -26.0% | -26.0% | -24.1% |
| FY2021 | -15.4% | -15.4% | -15.0% |
| FY2022 | 20.8% | 20.8% | 19.8% |
| FY2023 | -33.8% | -33.8% | -31.6% |
| FY2024 | -28.4% | -28.4% | -26.9% |
| FY2025 | -53.8% | -53.8% | -49.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | -26.0% | -26.0% | -24.1% |
| FY2021 | -15.4% | -15.4% | -15.0% |
| FY2022 | 20.8% | 20.8% | 19.8% |
| FY2023 | -33.8% | -33.8% | -31.6% |
| FY2024 | -28.4% | -28.4% | -26.9% |
| FY2025 | -53.8% | -53.8% | -49.0% |